EUVIMEDEUVIMED entdecken
Open Access

Self‐Reported Adverse Effects Associated With New Psychoactive Substance Use in a Sample of Adults From 20 US Cities

Nicole D Fitzgerald iD, Joseph J Palamar, Linda B Cottler

Drug and Alcohol Review · 2026

DOI: 10.1111/dar.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von Nicole D Fitzgerald und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Columbia Mailman School of Public Health, New York, New York, USA. Hauptthemen laut MEDLINE: Psychotropic Drugs, Substance-Related Disorders, Self Report, Illicit Drugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

As new psychoactive substances (NPS) continue to emerge both in the US and globally, research is needed to determine the extent of adverse effects associated with NPS use beyond poisonings or mortality to inform prevention and harm reduction efforts in this population.

Methods

Data were from the National Drug Early Warning System Rapid Street Reporting study, which uses a venue‐intercept design to survey adults (≥ 18 years) in US cities over weekend periods. Between January 2022 and November 2023, 6039 individuals were surveyed in 20 cities regarding their use of a range of NPS and other common drugs. Those reporting past 12‐month use of a drug were asked if they experienced a harmful or very unpleasant effect after use.

Results

Overall, among those reporting any past 12‐month NPS use ( n = 259), over a quarter (27.03%) reported experiencing an adverse effect related to the use of at least one NPS in the past 12 months. Among those reporting NPS use, those who also reported past 12‐month opioid use had over two times the prevalence of reporting an adverse effect related to NPS use (adjusted prevalence ratio 2.66, 95% confidence interval 1.41, 5.01). Symptom profiles were broadly similar between NPS and common drug classes. Discussion and Conclusions Adverse effects from NPS appear to be common among those self‐reporting NPS use, particularly among those reporting polysubstance use. More data are needed to determine event‐specific adverse outcomes involving the use of NPS and other drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotropic DrugsSubstance-Related DisordersSelf ReportIllicit DrugsHumansUnited StatesAdultFemaleMaleYoung AdultCitiesMiddle AgedAdolescent

Stichwörter der Autor:innen

adverse effectsnew psychoactive substancespolysubstance use

Substanzen

Psychotropic DrugsIllicit Drugs

Autor:innen und Institutionen

  • Department of Epidemiology, Columbia Mailman School of Public Health, New York, New York, USA.
  • Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Nicole D Fitzgerald

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Fitzgerald, N. D., Palamar, J. J., & Cottler, L. B. (2026). Self‐Reported Adverse Effects Associated With New Psychoactive Substance Use in a Sample of Adults From 20 US Cities. Drug and Alcohol Review. https://doi.org/10.1111/dar.70119

Vancouver

Fitzgerald ND, Palamar JJ, Cottler LB. Self‐Reported Adverse Effects Associated With New Psychoactive Substance Use in a Sample of Adults From 20 US Cities. Drug and Alcohol Review. 2026. doi:10.1111/dar.70119

BibTeX
@article{Fitzgerald2026,
  author = {Fitzgerald, Nicole D and Palamar, Joseph J and Cottler, Linda B},
  title = {Self‐Reported Adverse Effects Associated With New Psychoactive Substance Use in a Sample of Adults From 20 US Cities},
  journal = {Drug and Alcohol Review},
  year = {2026},
  doi = {10.1111/dar.70119}
}
Kostenlos starten →